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Knowledge, Technology and Law examines the interface between studies of law, science and society, 
from the perspectives of socio-legal studies and science and technology studies (STS). The 
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the analysis of their intersection(s) has become complex. Accordingly, scholars have borrowed from a 
range of disciplines and case studies to analyse not only how such intersections materialize, but also 
how and from where they should be approached. Notably, STS has provided a basis to explore the 
links between science and society, and socio-legal studies has offered many tools to understand the 
relationships between law and society. In recent years, a growing number of scholars have borrowed 
from both fields in order to further their efforts to understand the interconnectedness of law, science 
and society. This collection charts the important interface between studies of law, science and 
society, as explored from the perspectives of socio-legal studies and the increasingly influential field 
of STS. It brings together scholars from both areas to interrogate the joint roles of law and science in 
the construction and stabilization of socio-technical networks, objects, and standards, as well as their 
place in the production of contemporary social realities and subjectivities. 
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The voice of silence: UK patients’ silent resistance to the assisted reproduction 
regulations 
 
Ilke Turkmendag* 
 
Abstract 
This chapter examines the role of patient support networks in generating forms of resistance and 
enhancing engagement in the governance of assisted reproduction technologies in the UK. From 1 
April 2005, UK law was changed to allow children born
 
through gamete donation to access 
identifying details of the
 
donor. For a majority of fertility patients, this also meant that they came 
to find themselves on lengthy waiting lists due to donor shortages. Perhaps surprisingly, the voices 
of would-be parents - those who would be most affected by a contraction in donor supply - were 
not heard during the donor anonymity debate or thereafter. The would-be parents’ reluctance to 
mobilise around pressing claims against the removal of donor anonymity partly reflects the variety 
of ways in which they can avoid the impact of this legislation. Many fertility patients in the UK 
used online discussion forums hosted by patient support networks to show their reactions to the 
new law. These discussion boards were snowed under with posts about treatment opportunities in 
other jurisdictions, and the purchasing of sperm online. Support networks not only provided 
would-be parents with a forum to rehearse concerns about the law, but also enabled them to 
develop strategies to circumvent the limitations it imposed upon their reproductive freedom. The 
UK should take full advantage of the Internet and information technology to enhance stakeholder 
participation. 
* This work was supported by a Mildred Blaxter Post Doctoral Fellowship from the Foundation 
for the Sociology of Health and Illness. I am grateful to Emilie Cloatre and Martyn Pickersgill for 
their constructive comments. 
Introduction  
 
Since the 1990s, one of the most controversial changes to the UK’s Human Fertilisation and 
Embryology Act (HFE Act) concerned the information that is kept about the egg, sperm 
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(gametes) and embryo donors in donor registers. This information is held by the Human 
Fertilisation and Embryology Authority (HFEA), which is a quasi-autonomous non-
governmental organization (quango) set by the HFE Act in 1990 to license and regulate 
clinics that carry out in vitro fertilisation (IVF), other assisted conception techniques using 
human sperm, eggs and embryos, and embryo research.  
Originally, section 31(3) of the HFE Act 1990 allowed offspring conceived through 
gamete donation the right to apply for information about the donor when reaching the age of 
18. In practice, donors were asked to provide some non-identifying information, which could 
be passed to potential recipients. However, on 1 April 2005, with the implementation of the 
Human Fertilisation and Embryology Authority (Disclosure of Donor Information) 
Regulations 2004, UK law was changed to allow children born through gamete donation to 
access identifying details of the donor.
1
 Drawing on trends in adoption law the decision to 
abolish donor anonymity was strongly influenced by a discourse that asserted the ‘child's 
right-to-personal identity’, encouraged by the European Convention on Human Rights 
(ECHR)
2
.  
The removal of donor anonymity has aggravated the outgoing donor shortage since 
individuals were less likely to donate if their relatedness could one day be established.
3
 
Moreover, on 5 July 2007 the HFE Act was amended in order to bring the EU Tissues and 
Cells Directive (EUTCD) into UK law.
4
 The implementation of EUTCD’s voluntary and 
unpaid donations policy for tissues and cells has made it even more difficult to recover the 
donor shortage as donations cannot be promoted by financial incentives.
5
 As a result, fewer 
people now have access to the treatment in the UK.  
Perhaps surprisingly, neither during nor after the removal of donor anonymity did the 
government face organised resistance from would-be parents through classic avenues of 
opposition to new legislation; i.e, both those who cannot receive treatment due to the donor 
                                                 
1
 The Human Fertilisation and Embryology Authority (Disclosure of Donor Information) Regulations 2004 SI 
2004/1511. 
2 I Turkmendag, 'The Donor-conceived Child's "Right to Personal Identity": The Public Debate on Donor 
Anonymity in the United Kingdom' (2012) 39 Journal of Law and Society 58. European Convention for the 
Protection of Human Rights and Fundamental Freedoms 1950, ETS 5. The ECHR was incorporated into 
domestic law in the UK via the Human Rights Act 1998. 
3
 Turkmendag, Dingwall and Murphy (n 2) 
4  
Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting standards of 
quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of 
human tissues and cells [2004] L 102/48.There are also two supplementary Technical Directives: 2006/17/EC; 
2006/86/EC.
 
5
 I Turkmendag, ‘When Sperm Cannot Travel: Experiences of UK Would-Be Parents Seeking Treatment 
Abroad’ in ML Flear, A-M Farrell, TK Hervey and T Murphy (eds), European Law and New Health 
Technologies (Oxford University Press, 2013). 
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shortage, and those who might carry the burden of informing children of their origins if 
treatment were available and successful.
6
 Those who prefer anonymous donation are reluctant 
to press their claims because confidentiality matters to them.
7
 Even those who are pro-
openness may be reluctant to face publicity as undergoing fertility treatment, and using 
donated gametes are private matters. Presumably because they did not articulate their 
concerns in formal ways of communication (such as lodging complaints for a policy change), 
there has been little enquiry into the reactions of would-be parents to the new law. But, 
despite their reticence during the donor anonymity debate, would-be parents articulated 
anonymous protests against the new law on the discussion forums of online fertility support 
groups. In this chapter I examine such discussion forums in order to cast fresh light into the 
discourse of would-be parents that was propelled by the change to the HFE Act. I examine 
how strategies of legal avoidance and resistance to the new law were facilitated by the growth 
of an online community of would-be parents, and explore their impact on policy adjustments. 
The data form part of my on-going (since 2005) research into the socio-legal dimensions of 
reproductive care. 
 
Avoidance of the Law by the ‘Virtual’ Patient Communities 
 
Online forums are known to have transformed much of the movements and relationships that 
animate communities of would-be parents. As an example, Waldby (2008) argues that 
multilingual websites and Internet communication have made international partnerships and 
the possibilities for patients to travel abroad for treatment much easier. This, together with the 
legal possibilities offered by the European Union, have facilitated what is sometimes refereed 
as to ‘cross border reproductive care’ (CBRC): a form of medical tourism that enables 
patients to take advantage of differences in reproductive consumer cultures reflected in 
variations in the cost and availability of treatments, success rates, and waiting lists. The 
removal of donor anonymity in the UK, has resulted in an increasing number of would-be 
parents abroad to seek treatment, a movement facilitated by the availability of online support 
that Waldby describes.
8
 Indeed, the internet plays a significant role here, that I retrace 
through this chapter: through online discussion forums, it facilitates ongoing discourse among 
                                                 
6
 Turkmendag, Dingwall and Murphy (n 2) 
7
 Ibid. 
8
 F Shenfield et al, 'Cross Border Reproductive Care in Six European Countries' (2010) 25 Human Reproduction 
1361. 
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the patients, effectively creating a ‘virtual patient community’, a social aggregation based on 
common interest and intellectual and affective (rather than geographic) proximity. The virtual 
patient community that emerged around (and in antagonism to) the changes to the HFE Act 
did not promote the breaking of law, but instead its avoidance. Community members develop 
and share strategies to do this (i.e., how best to make use of CBRC), and mobilise around 
their contentions about the legal shift whilst remaining anonymous.  
In the UK the online discussion forums hosted by fertility support groups (e.g. 
Acebabes, fertilityfriends, INUK, More to Life and IVF.Net) or fertility clinics played a 
salient role (perhaps unintentionally) in helping potential patients to overcome their anxiety 
about receiving treatment away from home. Following the removal of donor anonymity, these 
forums were snowed under with posts about treatment opportunities in other jurisdictions. 
Those who wanted to receive treatment using anonymous gametes and those who were 
denied access to treatment at home for various reasons (donor shortage, being regarded as 
unfit parents) exchanged information about the jurisdictions where the treatments they 
needed would be available (e.g. standards of the clinics, the success rates, costs, quality of the 
aftercare, whether practitioners or nurses could speak English, and regulatory frameworks). 
Those who could not afford to travel abroad exchanged information about ‘backstreet’ 
arrangements (such as purchasing of sperm online).  In addition, these forums became a space 
in which patients could express their opposition to the new law without making their 
identities known (e.g. signing online petitions, discussing the HFEA’s decision-making 
processes, sending feedback through forum administrators, talking to journalists and 
researchers.). In what follows, I present data collected during a virtual ethnography on one of 
these discussion forums: Repromed (www.repromed.co.uk), which was hosted by the website 
of the Bristol Centre for Reproductive Medicine (BCRM).
9
 In doing so, I render visible the 
discreet ways in which would-be parents avoided, resisted, and ultimately expressed their 
opposition, to the new law. 
 
‘Would-be’ parents and the discussion forums of Repromed 
 
Repromed introduced itself as a website for anyone in the UK interested in reproductive 
medicine. Like many other patient support groups, Repromed was open to anyone, at any 
                                                 
9
 At the time of this study, the clinic behind the Repromed website was the University of Bristol’s, Centre for 
Reproductive Medicine. This centre has now merged with the Southmead Fertility Service. 
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stage of their treatment, offering an ideal platform to access to information about treatment 
techniques, clinics abroad, and other patients’ experiences at no or little cost (some patient 
groups may require a small subscription fee), quickly and anonymously from home. On the 
home page there was a link to the discussion area; there, the forum titles were listed. Each 
topic involved a question, or a brief introduction about the inquiry; for example: “Is anyone 
currently trying or pregnant with a donor conceived baby?” Forum administrators and 
moderators, who had the highest level of control over forum content, could turn forum 
features on and off, ban and remove users, edit and delete posts, and create users and groups. 
This gave them some control over the postings, although it might be rather difficult to 
monitor and manage such a large and continuously evolving content. By the time that I 
visited the website in 2006, users had posted 27,829 messages, on 704 topics, in 15 forums. 
The age range of the other 28 users was from 28 to 43. The average age was 35 and there 
were two modes (the most frequently occurring age in the distribution) at 35 and 40. 
Although more than 5000 postings were scanned, the final sample included 900 postings sent 
between 13 July 2005 and 26 April 2007.  
Posts on Repromed included inquiries as to where one could receive treatment abroad 
by using gametes from anonymous donors, stories about fertility travel, complaints about the 
long waiting lists and the donor shortage in the UK, and criticism of the new regulations. The 
data presented here draws mainly on the ‘Donor Gamete’ Forum on Repromed, which had the 
fullest coverage of donor anonymity. Although this study does not claim to be a definitive 
account of UK would-be parents who use online forums, Repromed was clearly one of the 
most active sites (based on the number of messages posted, and the depth of the threads) 
during this period and represents an important source of data on voices that were not fully 
heard in the public debates over ending donor anonymity. The extracts from the forum posts 
that I present herein are not edited, except for the references to clinics or names of websites 
where sperm can be purchased. 
 
Policy Processes and Patient Reactions 
 
Before this forum was set up, fertility travel was being addressed in other discussion forums 
on the website. One of the patients, Elaine, who was receiving treatment at the BCRM (the 
clinic that hosts Repromed), had decided to receive treatment in Spain; this was mainly due to 
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the removal of donor anonymity in the UK and consequent lengthening of waiting lists. She 
shared her experiences with other users of Repromed, eventually meeting in person and 
befriending six other women users who also ended up receiving treatment in Spain. 
According to Elaine, the fact that they were discussing their experiences on Repromed 
discussion forums was not well-received by the host clinic and the administrator set up a new 
‘Donor Gamete’ forum so that people receiving donor gamete treatment could interact in a 
setting separate from other patients of the clinic. It was established in November 2005 with 
the following disclaimer: 
 
After much discussion we have set up the Donor gamete forum. We are a little concerned 
about the oversees fertility treatment options as these are outside UK ethical and safety 
regulations, but we fully agree that UK patients receiving donor gamete treatment would 
benefit from mutual online support. 
 
Regards, Admin 
 
Most forum participants were on waiting lists for gamete donation
 
and clearly associated the 
donor shortage with the change
 
in the law to remove anonymity. Examples of posts 
expressing this view were as follows (all are excerpted from a thread about the options 
available for those who attempted to receive treatment in licensed clinics in the UK but for 
various reasons could not access the treatment they need):  
 
Apparently out of 500 applicants to give sperm in the last year only 2 actually do so, 
predominantly due the anonymity issue and the low sperm counts of the younger 
applicants. Very frightening stats don’t you think? (Mandy)  
 
i do think that the change in the law has got every thing to do with it especialy if you 
are donating eggs or sperm and you are haveing difficulty consiving yourself .i have 
also been told that sperm donations have gone down because there use to be alot of 
students that use to donate but have stoped because they dont want a knock on the 
door in 18 years do you know if it the same if you go out side theuk and have 
treatment and donate at the same time cause im not sure about that one from the first 
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time i went for icsi to now things seame to have got more compucated and expensive 
lol (Sheila). 
 
 
Prior to the removal of donor anonymity, a 2004 Department of Health survey of UK fertility 
clinics indicated widespread agreement that lifting anonymity would decrease donations.
10
 
During the spring of 2004, the HFEA conducted its own survey of clinics
 
to develop a 
detailed understanding of the current demand for,
 
and provision of, treatment using donated 
gametes or embryos,
 
as well as to identify relevant trends.
11
 The removal of donor anonymity 
was
 
the most frequently cited factor anticipated negatively to affect
 
sperm and egg donation 
by the clinics which were already suffering from a donor shortage. In other words, the donor 
crisis was hardly a surprise to the regulatory bodies.  
  In the following post, one user, Tara, drew attention to that the HFEA ignored the 
evidence provided by the clinics:  
 
They (HFEA) should have warned clinics to overstock a year ago in case this should 
happen. From what I could gather from the clinics I rang they had warned the HFEA 
that this would happen!! The HFEA knew there could be a dip in donors as this 
happened in Australia and New Zealand and Sweden, I would like to know if they 
ever recovered!! All I can say is well done (not) HFEA (Tara).  
 
If the donor shortage was predictable why then did HFEA take precautions? In 2007, 
the Department of Health and the National Gamete Donation Trust (NGDT) launched the 
‘Give a Toss’ campaign to raise awareness of donation and recruit new donors (critics of 
which campaign have accused the NGDT of alienating donor parents, would-be parents and 
donor-conceived children by perpetuating a ‘tacky’ image.)12  Other campaigns were 
launched throughout the country to promote sperm donation and the British Fertility Society 
established a working party to examine sperm donation in the UK. Its report was launched at 
                                                 
10
 Donor anonymity to be removed in UK. 242 Bionews  2004 < http://www.bionews.org.uk/page_11833.asp> 
accessed December 2012.  
11
 Human Fertilisation and Embryology Authority Sperm, Egg and Embryo Donation (SEED) policy review: 
Findings of the clinic survey.< http://www.hfea.gov.uk/docs/Clinics_survey_Seed_review.pdf> accessed 18 
November 2012. 
12
 McVeigh, K. Online ads for sperm donors called offensive. Guardian News and Media Limited 2007 
<http://www.guardian.co.uk/media/2007/mar/26/newmedia.advertising> accessed June 2012. 
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a HFEA meeting in February 2008. The report made a number of recommendations about 
how the existing pool of donors could be used to more effect: “the report gives a helpful 
impression of the current state of sperm donation services in the UK, showing an undeniable 
mismatch between supply and demand”. The HFEA’s response in July 2008 was that the 
Authority’s remit did not extend to the recruitment of donors; this was a matter for the sector 
and should be addressed as a matter of urgency.
13
  
During the donor anonymity public debate The HFEA made it clear that it supported 
lifting the anonymity. The then chair of the HFEA, Suzi Leather noted that ‘[W]e have been 
asking for this for a long time. I can understand why people want to know who their genetic 
parents are’.14 In the following post Tara expressed her anger about the view that the child’s 
right to know should be championed at any cost, rather than weighed against the competing 
interests of would-be parents: 
 
Anyway on another note we should thanks Dame Suzi Leather and her syndicate for 
causing this mess!! I wouldnt be surprised if a couple took them to the court of human 
rights – essentially they are stopping couples having a baby!! To me thats enfringing 
on our human rights. Of course this is my personal opinion, but I havent yet found 
anyone who is happy with what the HFEA have done (Tara).  
 
One forum user, Sylvia, claimed that in order to resolve the sperm shortage the law 
should be changed back; she believed that anonymity should be reinstated, and produced a 
petition to that effect:  
  
if you think sperm donors should be legally allowed to remain anonymous please sign 
my petition. i am petitioning the prime minister of the uk to change the law so sperm 
donors can go back to being anonymous so the sperm shortage can be resolved. if you 
agree with this please sign at the following link: http://petitions.pm.gov.uk/sperm-
donor-anon/ (Sylvia). 
 
                                                 
13
 L Jardin, ‘BFS report on sperm donation in the UK: HFEA response’ (Human Fertilisation and Embryology 
Authority 2008) 
14
 S Leather,’ Sperm donors to lose anonymity. BBC News, 21 January 2004’(BBC News, 2004) 
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Like Tara, she framed the legislative changes as explicitly curtailing her and others’ 
reproductive freedom: 
 
i think anonymity should be brought back after watching a documentary on it. being 
someone who possibly may need a sperm donor's help in the future id rather not be 
waiting for years because of the shortage if you agree could you please sign my 
petition. i understand the reasons why it shouldn't but why should we prevent a loving 
couple from having the child they wish to have?  
come on sign it if you agree :D (Sylvia). 
 
In her response to Sylvia’s post, Dorothy says: 
 
I have signed your petition as I have used sperm donor in the past and though we were 
not successful I was shocked for other people at the huge decline in donors when the 
law was changed. (Dorothy) 
 
Signing petitions is one of the ways that patients can lodge formal complains. 
However, it might be problematic for those who have confidentiality concerns. For example, 
one of the users, Hannah had twins through surrogacy arrangements in USA and did not want 
this to be known. According to UK law, the surrogate is considered a child’s legal mother.15 
If the origins of the twins were known, Hannah would have to formally adopt them in order 
to become legally recognised as their mother. Hence, she was very careful about making 
formal complaints that might reveal the origins of her children. Another user, Cheryl opted 
for adoption after failed attempts to achieve pregnancy. She also had confidentiality concerns 
about making herself known as she did not know how that would affect her chances of 
adopting a child.  
In order to circumvent the challenges imposed by the law, many would-be parents 
claimed that they or others might or would go abroad in order to obtain treatment. As Tara 
put it:  
 
                                                 
15
 The Human Fertilisation and Embryology Act 2008 section 33 (or the equivalent HFE Act 1990 section 27 for 
conceptions before 6 April 2009) provides that the woman who gives birth to a child is the legal mother.  
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Now it has happened, where and what do people needing donor sperm do??? If clinics 
dont start recruiting their own donors then we will have to go to the ends of the Earth 
to try and get one, thats our only choice, its so unfair (Tara). 
 
Some commentators consider CBRC as a ‘reproductive exile’ where patients who are 
denied access to treatment at home are led to find a legal regime under which the treatment 
they need will be available.
16
 For example, in Ireland, where abortion is not permissible 
unless there is a risk to the pregnant woman’s life, between January 1980 and December 
2010, at least 147,912 women travelled from the Republic of Ireland to terminate their 
pregnancies abroad.
17
 Often due to the complicated travel arrangements these abortions are 
performed later than is preferred, creating emotional upset for women at an already stressful 
time.18 Further, only those who can afford to travel can escape the law’s strictures. Again, in 
Ireland, both illegal abortions, and the use of illegal abortion pills have become a necessity 
for women who cannot travel abroad to end their pregnancies.
19
 Similarly, in Repromed 
discussion boards, some of the users ask for others’ opinions about ‘backstreet’ 
arrangements: 
 
I have found this company on the web and wanted to know your views: [the web-
site’s URL] Having quickly read it through it seems as tho they send you the sperm 
and you self inseminate (?!) for under £400. I know people have been going abroad, 
but i can't find a place that does D IUI (Suzanne). 
 
In one reply, Tara says:  
 
Also there is another site [the web-site’s URL] as anyone thought or used this one??? 
I have heard they are fairly good. I have to say it makes me wonder whether all the 
                                                 
16
 R Matorras, 'Reproductive Exile versus Reproductive Tourism' (2005) 20 Human Reproduction 3571. 
17
 Irish Family Planning Association website. 
18
 ibid. 
19
 S McGuinness, 'A, B, and C Leads To D (For Delegation!): A, B and C v. Ireland 25579/05 [2010] ECHR 
2032' (2011) 19 Medical Law Review 476. 
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sperm donors that went through clinics and wanted to remain anonymous are now 
going to these places in order to help people needing it??!!(Tara). 
 
Elaine advices this user to seek treatment in Spain using a cheap airline: 
 
Try xxx [a clinic in Spain]- anonymous donor sperm is 260 Euros per go and I flew 
from Bristol to Barcelona for £50 each way! (Elaine). 
 
In another post, after complaining about the fees that each couple has to pay to 
undergo treatment, Tara addresses the risks of ‘backstreet’ arrangements. She notes that the 
new law leads people to consider less legitimate ways of overcoming their childlessness and 
to take health risks. For example, one can use the ‘turkey baster’ method and achieve 
pregnancy using fresh sperm, but this sperm cannot be screened for certain diseases. Licensed 
clinics are required to freeze and store the sperm for six months, the incubation period of 
HIV, before insemination to ensure that it is virus free.  
 
basically they are ruining couples (like us) chances of having a child using donor or 
want for a better word 'harder'- they are actually going to force this underground.  
Couples will go to other agencies (not so legitimate) and abroad to get donors is that 
fair??? The sad thing is that the women like us may not have as much in the way of 
protection against certain things like HIV etc I really think they have made the whole 
donor issue a lot worse (Tara). 
 
Patients seem to be aware of risks involved in purchasing sperm online hence they 
consult each other about the safety of providers. However, further legislative changes have 
curtailed even their ability to (legally) assess and respond to such risks themselves. Following 
the implementation of EUTCD within the UK, Internet sperm providers came to be subject to 
the same rules as HFEA licensed clinics. Thus, the procurement, testing, processing or 
distribution of any embryo or gametes intended for ‘human use’ must now be licensed by the 
HFEA or be subject to an agreement with a licensed service. Therefore, even if would-be 
parents would like to take a risk with fresh sperm, they have to think twice. The current Chair 
of the HFEA, Professor Lisa Jardine, has “strongly” advised “any person who became aware 
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that a person or organisation may be procuring, testing, processing or distributing gametes 
without a licence to contact the police”.20  
On the other hand, if patients are considering obtaining sperm, eggs or embryos from 
within the EU, a licensed UK clinic can organize for a transfer to be made from that country. 
However, the sperm, eggs or embryos transferred must meet UK requirements. Would-be 
parents can also exercise their rights to travel within the EU to receive gametes or embryos 
from a clinic even if that clinic does not comply with UK standards.
21
   
Hence, would-be parents feel that the changes made to the HFE Act enjoins them to 
seek treatment abroad. One forum user, Suzanne, was a patient at a clinic which found a 
donor for her; however, he did not match either her physical characteristics or those of her 
husband. Suzanne and her partner thus chose a donor profile from Spain, to be imported by 
their licensed clinic, but the clinic informed them that UK law prohibited the purchase of 
sperm from an anonymous donor. If would-be parents cannot purchase anonymous sperm 
online, or have the sperm imported by a licensed clinic, they construct themselves as having 
no option but to go abroad for treatment. Other reasons behind reproductive travel are 
addressed in the following post by Elaine: 
 
In the end, I think more and more people will go to Europe for treatment, as it costs 
the same, is completely anonymous, has no waiting lists and, best of all, not bl**dy 
HFEA!!! That's not to say they aren't regulated, but by sensible people with our 
interests at heart!!! (Elaine). 
 
The following post by Tom summarises many of the issues raised by other users: 
 
There are many infertility newsgroups out there, so it becomes quite easy to compare 
the approaches taken by different clinics. Some UK clinics seem to be several steps 
off the pace of both other UK centres and overseas centres. Treatments used almost 
routinely in other centres are dismissed with the excuse that it is not current clinic 
policy, or the treatment isn't proven. The result is that the patient feels that they are 
                                                 
20 L Jardine, 'Internet sperm providers are illegal' (Guardian News and Media Limited 2008) 
<http://www.guardian.co.uk/uk/2008/sep/23/ukcrime.law1> accessed 23 May 2012 
21 Under the directly effective freedom to provide and receive services under Article 56 Treaty on the 
Functioning of the European Union: R v Human Fertilization and Embryology Authority, ex parte Blood [1997] 
2 All ER 687 (CA). See T K Hervey, ‘Buy Baby: The European Union and Regulation of Human Reproduction’ 
(1998) 18 Oxford Journal Legal Studies 207. 
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not being treated as an individual, and they are left with many unresolved questions 
about their particular situation, and they are paying a premium price for this 
unsatisfactory state.  
 
In many cases patients find that they are managing their own treatment, pushing the 
medics to try something outside the standard for that clinic. This is probably the most 
wearing part of treatment for infertility, dealing with a system that you are not part of. 
It is probably also the reason why many more women in the UK will turn to overseas 
centres. 
Overseas treatment will also be favoured because any form of medical treatment in 
the UK means that at some stage the patient will come up against the NHS, a hugely 
expensive medical insurance scheme which has now turned into a useless quivering 
jelly of administrators, processes and targets; fertility treatment is way down the list 
of priorities (Tom). 
 
The accounts I have presented indicate that forums users had significant difficulties in 
accessing the treatment they sought; this was deemed to be due to the donor shortage, which 
was itself accounted for as a consequence of legislative change. Following the removal of 
donor anonymity, would-be parents who could not access treatment due to the donor 
shortage, and/or preferred anonymous donors constructed themselves as having no choice but 
to seek treatment abroad or purchase gametes (sperm) through the Internet.  
Although discussion forums on online support groups are - in theory - rather 
democratic places where people can express their opinions freely, they are still subject to 
control by forum moderators. The power of the moderators was exercised when, in May 
2006, Repromed’s ‘Egg and Sperm Donation’ forum was suspended. This action followed the 
HFEA’s warning against reproductive care abroad. In April 2006, the then chair of the 
HFEA, Suzi Leather, issued a public statement warning British citizens against the poorly 
regulated treatment in overseas clinics: 
 
We know that a relatively small number of people choose to travel abroad to undergo 
fertility treatment and that sometimes the treatment is packaged as a "holiday" where 
the patient can convalesce in the sun. However, we are concerned about people who 
choose to have their treatment abroad should know about the potential risks. (…)It is 
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very sad when we receive complaints from patients about their treatment abroad and 
we are not able to help or reassure them. We would urge patients to think twice and 
consider the risks and implications before going abroad for treatment.
22
 
[emphasis added]. 
 
The Repromed administrator informed me that the ‘Egg and Sperm Donation’ forum 
had been closed because members of the HFEA-licensed centre hosting the site were 
concerned about the increasing number of posts advising participants about offshore facilities 
for assisted conception using anonymous gametes. The forum was reopened five months later 
with a disclaimer stating: “In view of popular demand the donor gamete forum has been 
reopened, but anyone thinking of going abroad for treatment should first consider the 
guidance provided by the HFEA, which is quoted below.” The HFEA’s warning about 
fertility treatment abroad and Leather’s speech were both quoted. Repromed users posted a 
range of responses to the disclaimer, expressing discontent about the HFEA’s approach to 
fertility travel:  
 
I'd like to see the HFEA or perhaps other organisation carry out a full investigation 
into the standards of clinics abroad, to provide some hard evidence that will allow 
potential patients to make their minds up once fully informed (Will). 
 
I do think the HFEA is very heavy-handed in its approach to this issue, and has also 
made some very poor regulatory decisions (especially about donor anonymity, for 
example) which may well end up encouraging people to seek treatment elsewhere.  I 
guess they would open to considerable criticism if it could be shown that, in order to 
avoid the consequences of their approach, lots of people are travelling abroad for 
treatment, so now they are trying to discourage them with 'scare tactics'.  Not a very 
grown up approach, really (Melissa). 
 
I feel that if donor anonymity was guaranteed in the UK you wouldn’t be going to 
abroad anyway. That’s down to the government perhaps in places they shouldn’t 
(Gemma). 
 
                                                 
22
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Treatment' (HFEA 2006) < http://www.hfea.gov.uk/632.html> accessed 23 May 2012. 
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Some individuals grounded their critique of the HFEA with reflections on the high 
quality treatment they had received abroad; in so doing they (re)positioned foreign clinics not 
as sites of risk and uncertainty, but as morally progressive and highly professional centres of 
care: 
 
 
I really do get fed up with the HFEA scaremongering about going abroad, especially 
when they've done so much to prevent successful treatment in the UK, for 
example, removing donor anonymity and successfully wiping out the entire UK sperm 
bank in one go!!!!!!I for one can only express my utmost admiration at the extremely 
expert and professional treatment I received at [name of the clinic], which was vastly 
better than the treatment I received in the UK and resulted in my gorgeous baby at the 
first attempt. In total, six of us became pregnant after only one or two transfers after 
going to [name of the clinic], two with twins, which would never have happened if 
we'd remained in the UK. I think that says it all! (Elaine) 
 
On the note of the HFEA 'warning' all I will say is that I was offered a very high 
quality individualised treatment at xxx in Spain. I very carefully researched a number 
of clinics abroad as there were no further options left for me in the UK - I did not 
have 5 years to wait for Egg Donation in the UK. I was offered a service and support 
at xxx that was not on offer at any of the three clinics I was under in the UK. Will, I 
agree whole heartedly with you - it would be good for the HFEA to produce some 
good statistical evidence of what they claim - I'd like to know just how many people 
have complained to them about treatment abroad (Kelly). 
 
The HFEA’s warning about the risks of off-shore treatment - including countries 
which were popular EU destinations where assisted conception is highly regulated and 
standards of fertility clinics are demonstrably as high, if not better, than those in the UK - 
seemed to have frustrated the would-be parents; they saw themselves as having no choice but 
to seek treatment abroad as a consequence of the legal shift promoted by the HFEA itself. It 
was not until the largest fertility support group of the UK brought patients’ views together 
their voices were heard.  
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Bringing patients’ views together 
 
Following the removal of donor anonymity, while hundreds of fertility patients were 
protesting the new policy through various online patient support networks, a fertility travel 
survey conducted by INUK (Infertility Network UK) in 2008 brought these opinions together 
for the first time.
23
 INUK had 339 responses to its survey, which explored patient experiences 
of cross-border treatment. The results were striking: 76 per cent of respondents stated that 
they would consider going abroad for treatment (in particular, to receive egg donation). 
Further, 120 of the 339 (35 per cent) respondents answered the question “Which country did 
you go to for your treatment?”; the most popular response was   Spain, which maintains the 
donor anonymity for fertility treatment. At least three times as many patients went there as 
anywhere else. 
Although the INUK study received little recognition by public bodies, its findings 
were confirmed by the European Society of Human Reproduction and Embryology (ESHRE) 
Task Force, which undertook the most comprehensive study on cross border reproductive 
care to-date. The ESHRE survey contained data from 46 clinics across Europe, including 53 
patients travelling from the UK. 34 per cent of UK resident patients – more than any other 
nationality within Europe – cited access issues as their reason for travelling abroad.24  
 Findings from a recent qualitative study of UK residents showed that the four most 
commonly cited reasons for travel were: donor shortages in the UK (27 cases), cost (13 
cases), perceived better success rates overseas (12 cases) and previous unsatisfactory care in 
the UK (7 cases).  Overall, ‘a desire for timely and affordable treatment with donor gametes’ 
was evident in 71% of cases, making donor conception the most sought after treatment by the 
CBRC travellers.  Most patients sought treatment within European borders, the most popular 
destinations being Spain and Czech Republic.
25
  
 The growing evidence around reproductive tourism led the HFEA to move away from 
solely administering warnings, to critical engagements with its policy. In August 2010, the 
Authority launched a full, public consultation into sperm and egg donation policies. In the 
consultation document, the HFEA noted that the landscape of donation had changed since the 
Authority looked at their rules in 2005, and it emphasized that it would like to update these if 
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necessary. It was acknowledged that the demand for donor treatment in the UK was greater 
than the supply of donors and that the removal of donor anonymity might have exacerbated 
the shortage. The Authority further noted that the shortage of donors resulted in long waiting 
times for treatment, with reports of UK waiting times of three to five years for donor eggs. 
Concerns were also expressed that some fertility centres overseas may offer substandard 
treatment, and that increasing numbers of people are purchasing unscreened sperm on the 
Internet.
26
 The HFEA asked if gamete supply could be improved by a change in policy, or 
withdrawal from commitments under the EUTCD.
27
   
 The HFEA received a record number of responses to its consultation, with over 2400 
surveys completed by around 1100 people. The first set of decisions made by the Authority in 
response was that the maximum number of families that an individual donor can donate to 
should not be changed. The HFEA also decided to issue guidance stating that sperm and eggs 
should not be mixed if they come from very close genetic relatives. Further, the allowable 
compensation amounts for gamete donors have been increased: Egg donors can now receive 
£750 per cycle of donation, whilst sperm donors can receive a £35 fee per individual visit to a 
clinic.
28
 Finally, the HFEA decided to take a more proactive approach to donor recruitment 
and established a National Donation Strategy Group. Chaired by Professor Sheila McLean, 
the Group will bring together a wide range of experts in order to enhance the information that 
donors receive, develop new approaches to raising awareness of donation, and ascertain how 
the care of donors can be improved. However, it is questionable whether any of these 
measures can improve the UK’s donor conception policy in terms of its acceptability to users, 
unless stakeholders’ views are central to the HFEA’s policy decisions.  
 
Conclusion 
 
The virtual ethnography study presented in this chapter offers some potentially important 
insights into how would-be parents negotiate the issues of donor gamete donation 
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interactively and collectively on discussion boards. The topics generated by users of 
Repromed provide an indication of those matters they perceive as important or problematic 
with regards to donation. The most important issue that users raise is that, despite the 
warnings of a likely donor shortage, the government lifted anonymity at the expense of 
would-be parents’ access to treatment, and the HFEA should have taken measures to avoid 
the (predicatable) crisis that resulted from this legislative shift.  
 The continued shortage of donor gametes means that UK patients have to wait longer 
for treatment and have less choice with respect to donor characteristics. In response, we can 
see, via discussion threads about fertility travel and online sperm providers, that would-be 
parents have come to experiment with new ways of contesting the law, and - more 
importantly - novel means of avoiding it. The user accounts indicate that donor shortage 
problems lead couples to find alternative solutions to their childlessness; in particular, would-
be parents in the UK have readily available alternatives in their access to treatment in other 
EU nations. Success rates, the lower cost of treatment, donor availability, and anonymity 
make clinics abroad increasingly attractive. Yet, the HFEA warn against their use, creating 
further frustration.  
 The posts on the patient forums that I presented here suggest that patients feel their 
views are ignored by the HFEA in policy-making. But there is little they can do to have their 
voices heard without compromising their anonymity. Furthermore, the pursuit of a child is, to 
many would-be parents, a considerably demanding task: physically, emotionally, and in terms 
of time. Little space remains for lobbying when pregnancy is still to be achieved. Finally, 
being a would-be parent is a transitional phase: once pregnant, individuals’ priorities might 
change, and campaigning for new policy to address the needs of others is less salient once 
one’s own needs have been met.  
 It is important at this point to clarify that I am not claiming that would-be parents are 
completely divorced from more influential policy actors and processes. Indeed, patients use 
online environments to make their voices audible to policy-makers: they participate in online 
surveys, connect with journalists and researchers who recruit interviewees, and sign 
electronic petitions. However, in effect, UK would-be parents are caught in a double bind: 
those who are directly affected by the legal shift may be reluctant to press their claims 
because confidentiality matters to them. Given this reticence, their voices are not taken into 
consideration by public bodies, like the HFEA.   
  Since the passing of the Act 1990, some academic and political commentators 
have questioned whether the regulatory model adapted for the HFEA was acceptable to the 
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general public, or to the major stakeholders, those who are directly affected by the law.
29
 
Subsequently, the HFEA has faced several legal challenges and its policy decisions were 
criticised by the House of Commons Science & Technology Committee: “democracy is not 
served by unelected quangos taking decisions on behalf of Parliament authorisation” 30. In 
one of these legal challenges in 2004, the Court of Appeal confirmed that the HFEA had the 
legal authority to regulate these areas: “Parliament has placed that choice in the hands of the 
HFEA”.31 But how does the HFEA make these choices? During the public debate over 
ending donor anonymity it was clear that the proposed legal shift would create a donor crisis, 
and as a result, fewer people would have access to treatment. But the would-be parents’ 
interests were not a paramount concern to the Authority. The then chair of the HFEA made it 
clear that she viewed the principal of the welfare of the child as fundamental, despite the fact 
that the HFE Act only requires that this should be ‘taken into account’.32   
 As Dawson argues, the HFEA’s inspector role is vital to ensure the clinics are fully 
licensed and monitored.
33
 On the other hand, the recent consultation might be an opportunity 
to separate or improve the Authority’s approach to policy-making. Arguably, the UK assisted 
conception regulations may benefit from a more democratic decision-making process where 
the ‘conflicting’ interests of the stakeholders are fully and equally taken into account. This 
might include more evidence-based policy making, and taking full advantage of the Internet 
and information technology to enhance stakeholder participation especially to reach out those 
who cannot use transparent and formal modes of communication due to their confidentiality 
concerns, like the would-be parents in this study. 
Finally, it should be noted that the passage of the Public Bodies Act 2011 made it 
possible to transfer the functions of quangos (including the HFEA and Human Tissue 
Authority) elsewhere, without opening up the original Act that created them.
34
 The HFEA is 
one of several quangos set to be abolished, in order to meet the UK Government's aim of 
cutting National Health Services (NHS) costs. On 28 June 2012 the government launched a 
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consultation on the future of the HFEA to consider whether the regulators’ responsibilities 
should move to the Care Quality Commission (CQC) and the Health Research Authority 
(HRA).
35
 Consequently, the likelihood of current HFEA deliberations into mechanisms to 
increase donation being successfully translated into practice is unclear. Regardless, it is clear 
that future efforts to govern the interactions between law, biomedical knowledge and 
reproductive practice keep in mind the limitations of authority and the creativity of subjects, 
and endeavour to seek solutions that satisfy the hopes and aims of both regulators and 
regulatees in democratically-defensible ways. 
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